<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Overcoming Acquired Resistance in NSCLC with Targeted Beam Irradiation in Combination with Targeted Agents

Lung cancer is the largest cancer killer with poor 5-year survival rate. Non-small cell lung cancer (NSCLC) patients undergo primary, adjuvant or neoadjuvant radiotherapy treatment for NSCLC with image-guided radiotherapy (IGRT) being widely used to treat cancer patients providing beneft with more accurate treatment plans and reduced side effects.